New insights into the role of autophagy in tumor immune microenvironment

International Journal of Molecular Sciences

Volumn 18, Issue 7, 2017, Pages

  Li, Chia Jung ^a   Liao, Wan Ting ^a,b   Wu, Meng Yu ^c   Chu, Pei Yi ^a,d,e  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI TZU CHI HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Autophagy; Tumor immunity; Tumor immunotherapy; Tumor microenvironment

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANTIGEN PRESENTING CELL; AUTOPHAGY; CANCER THERAPY; CARCINOGENESIS; CELL AGGREGATION; CELL KILLING; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; METASTASIS; NATURAL KILLER CELL; NEUTROPHIL; REVIEW; TUMOR ESCAPE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; ANIMAL; GENE REGULATORY NETWORK; IMMUNOLOGY; NEOPLASM; PATHOLOGY;

ANIMALS; AUTOPHAGY; GENE REGULATORY NETWORKS; HUMANS; IMMUNOTHERAPY; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 85026219642     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms18071566     Document Type: Review

References (89)

1. Shibutani, S.T.; Saitoh, T.; Nowag, H.; Munz, C.; Yoshimori, T. Autophagy and autophagy-related proteins in the immune system. Nat. Immunol. 2015, 16, 1014–1024. [CrossRef] [PubMed]
2. Glick, D.; Barth, S.; Macleod, K.F. Autophagy: Cellular and molecular mechanisms. J. Pathol. 2010, 221, 3–12. [CrossRef] [PubMed]
3. Yin, Z.; Pascual, C.; Klionsky, D.J. Autophagy: Machinery and regulation. Microb. Cell 2016, 3, 588–596. [CrossRef] [PubMed]
4. Periyasamy-Thandavan, S.; Jiang, M.; Schoenlein, P.; Dong, Z. Autophagy: Molecular machinery, regulation, and implications for renal pathophysiology. Am. J. Physiol. Ren. Physiol. 2009, 297, F244–F256. [CrossRef] [PubMed]
5. Yang, Z.; Klionsky, D.J. Mammalian autophagy: Core molecular machinery and signaling regulation. Curr. Opin. Cell Biol. 2010, 22, 124–131. [CrossRef] [PubMed]
6. Li, W.; Yang, Q.; Mao, Z. Chaperone-mediated autophagy: Machinery, regulation and biological consequences. Cell. Mol. Life Sci. 2011, 68, 749–763. [CrossRef] [PubMed]
7. Vikram, A.; Anish, R.; Kumar, A.; Tripathi, D.N.; Kaundal, R.K. Oxidative stress and autophagy in metabolism and longevity. Oxid. Med. Cell. Longev. 2017, 2017, 3451528. [CrossRef] [PubMed]
8. Wu, Q.; Yang, Z.; Nie, Y.; Shi, Y.; Fan, D. Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches. Cancer Lett. 2014, 347, 159–166. [CrossRef] [PubMed]
9. Xie, Y.; Kang, R.; Sun, X.; Zhong, M.; Huang, J.; Klionsky, D.J.; Tang, D. Posttranslational modification of autophagy-related proteins in macroautophagy. Autophagy 2015, 11, 28–45. [CrossRef] [PubMed]
10. Jung, C.H.; Jun, C.B.; Ro, S.H.; Kim, Y.M.; Otto, N.M.; Cao, J.; Kundu, M.; Kim, D.H. ULK–Atg13–FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20, 1992–2003. [CrossRef] [PubMed]
11. Jung, C.H.; Ro, S.H.; Cao, J.; Otto, N.M.; Kim, D.H. mTOR regulation of autophagy. FEBS Lett. 2010, 584, 1287–1295. [CrossRef] [PubMed]
12. Lee, Y.J.; Jang, B.K. The role of autophagy in hepatocellular carcinoma. Int. J. Mol. Sci. 2015, 16, 26629–26643. [CrossRef] [PubMed]
13. Ranjan, A.; Iwakuma, T. Non-canonical cell death induced by p53. Int. J. Mol. Sci. 2016, 17, 2068. [CrossRef] [PubMed]
14. Jing, K.; Song, K.S.; Shin, S.; Kim, N.; Jeong, S.; Oh, H.R.; Park, J.H.; Seo, K.S.; Heo, J.Y.; Han, J.; et al. Docosahexaenoic acid induces autophagy through p53/AMPK/mTOR signaling and promotes apoptosis in human cancer cells harboring wild-type p53. Autophagy 2011, 7, 1348–1358. [CrossRef] [PubMed]
15. Czarny, P.; Pawlowska, E.; Bialkowska-Warzecha, J.; Kaarniranta, K.; Blasiak, J. Autophagy in DNA damage response. Int. J. Mol. Sci. 2015, 16, 2641–2662. [CrossRef] [PubMed]
16. Zhou, J.; Yao, K.; Zhang, Y.; Chen, G.; Lai, K.; Yin, H.; Yu, Y. Thioredoxin binding protein-2 regulates autophagy of human lens epithelial cells under oxidative stress via inhibition of Akt phosphorylation. Oxid. Med. Cell. Longev. 2016, 2016, 4856431. [CrossRef] [PubMed]
17. Zhang, M.Y.; Gou, W.F.; Zhao, S.; Mao, X.Y.; Zheng, Z.H.; Takano, Y.; Zheng, H.C. Beclin 1 expression is closely linked to colorectal carcinogenesis and distant metastasis of colorectal carcinoma. Int. J. Mol. Sci. 2014, 15, 14372–14385. [CrossRef] [PubMed]
18. Avalos, Y.; Canales, J.; Bravo-Sagua, R.; Criollo, A.; Lavandero, S.; Quest, A.F. Tumor suppression and promotion by autophagy. BioMed Res. Int. 2014, 2014, 603980. [CrossRef] [PubMed]
19. Rohatgi, R.A.; Janusis, J.; Leonard, D.; Bellvé, K.D.; Fogarty, K.E.; Baehrecke, E.H.; Corvera, S.; Shaw, L.M. Beclin 1 regulates growth factor receptor signaling in breast cancer. Oncogene 2015, 34, 5352–5362. [CrossRef] [PubMed]
20. Wang, X.; Du, Z.; Li, L.; Shi, M.; Yu, Y. Beclin 1 and p62 expression in non-small cell lung cancer: Relation with malignant behaviors and clinical outcome. Int. J. Clin. Exp. Pathol. 2015, 8, 10644–10652. [PubMed]
21. Jiang, Z.F.; Shao, L.J.; Wang, W.M.; Yan, X.B.; Liu, R.Y. Decreased expression of beclin-1 and LC3 in human lung cancer. Mol. Biol. Rep. 2012, 39, 259–267. [CrossRef] [PubMed]
22. Qu, X.; Yu, J.; Bhagat, G.; Furuya, N.; Hibshoosh, H.; Troxel, A.; Rosen, J.; Eskelinen, E.L.; Mizushima, N.; Ohsumi, Y.; et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Investig. 2003, 112, 1809–1820. [CrossRef] [PubMed]
23. Nicotra, G.; Mercalli, F.; Peracchio, C.; Castino, R.; Follo, C.; Valente, G.; Isidoro, C. Autophagy-active beclin-1 correlates with favourable clinical outcome in non-Hodgkin lymphomas. Mod. Pathol. 2010, 23, 937–950. [CrossRef] [PubMed]
24. Xie, J.; Wang, X.; Proud, C.G. mTOR inhibitors in cancer therapy. F1000Research 2016, 5. [CrossRef] [PubMed]
25. Tang, M.K.; Kwong, A.; Tam, K.F.; Cheung, A.N.; Ngan, H.Y.; Xia, W.; Wong, A.S. BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis. Cancer Lett. 2014, 346, 139–147. [CrossRef] [PubMed]
26. Laddha, S.V.; Ganesan, S.; Chan, C.S.; White, E. Mutational landscape of the essential autophagy gene BECN1 in human cancers. Mol. Cancer Res. 2014, 12, 485–490. [CrossRef] [PubMed]
27. Mazure, N.M.; Pouyssegur, J. Hypoxia-induced autophagy: Cell death or cell survival? Curr. Opin. Cell Biol. 2010, 22, 177–180. [CrossRef] [PubMed]
28. Fang, Y.; Tan, J.; Zhang, Q. Signaling pathways and mechanisms of hypoxia-induced autophagy in the animal cells. Cell Biol. Int. 2015, 39, 891–898. [CrossRef] [PubMed]
29. Paredes-Juarez, G.A.; Sahasrabudhe, N.M.; Tjoelker, R.S.; de Haan, B.J.; Engelse, M.A.; de Koning, E.J.; Faas, M.M.; de Vos, P. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1. Sci. Rep. 2015, 5, 14623. [CrossRef] [PubMed]
30. Zhao, L.; Bai, C.; Shao, Y.; Guan, M.; Jia, N.; Xiao, Y.; Qiu, H.; Zhang, F.; Yang, T.; Zhong, G.; et al. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer. Cancer Lett. 2011, 310, 134–139. [CrossRef] [PubMed]
31. Xu, X.D.; Zhao, Y.; Zhang, M.; He, R.Z.; Shi, X.H.; Guo, X.J.; Shi, C.J.; Peng, F.; Wang, M.; Shen, M.; et al. Inhibition of autophagy by deguelin sensitizes pancreatic cancer cells to doxorubicin. Int. J. Mol. Sci. 2017, 18, 370. [CrossRef] [PubMed]
32. Liu, G.; Pei, F.; Yang, F.; Li, L.; Amin, A.D.; Liu, S.; Buchan, J.R.; Cho, W.C. Role of Autophagy and apoptosis in non-small-cell lung cancer. Int. J. Mol. Sci. 2017, 18, 367. [CrossRef] [PubMed]
33. Du, H.; Yang, W.; Chen, L.; Shi, M.; Seewoo, V.; Wang, J.; Lin, A.; Liu, Z.; Qiu, W. Role of autophagy in resistance to oxaliplatin in hepatocellular carcinoma cells. Oncol. Rep. 2012, 27, 143–150. [PubMed]
34. Liu, L.; Liao, J.Z.; He, X.X.; Li, P.Y. The role of autophagy in hepatocellular carcinoma: Friend or foe. Oncotarget 2017. [CrossRef] [PubMed]
35. Schauer, I.G.; Zhang, J.; Xing, Z.; Guo, X.; Mercado-Uribe, I.; Sood, A.K.; Huang, P.; Liu, J. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts. Neoplasia 2013, 15, 409–420. [CrossRef] [PubMed]
36. Borthwick, L.A. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin. Immunopathol. 2016, 38, 517–534. [CrossRef] [PubMed]
37. Iannitti, R.G.; Napolioni, V.; Oikonomou, V.; de Luca, A.; Galosi, C.; Pariano, M.; Massi-Benedetti, C.; Borghi, M.; Puccetti, M.; Lucidi, V.; et al. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat. Commun. 2016, 7, 10791. [CrossRef] [PubMed]
38. Bockerstett, K.A.; DiPaolo, R.J. Regulation of gastric carcinogenesis by inflammatory cytokines. Cell. Mol. Gastroenterol. Hepatol. 2017, 4, 47–53. [CrossRef] [PubMed]
39. Yang, Y.Q.; Dong, W.J.; Yin, X.F.; Xu, Y.N.; Yang, Y.; Wang, J.J.; Yuan, S.J.; Xiao, J.; DeLong, J.H.; Chu, L.; et al. Interferon-related secretome from direct interaction between immune cells and tumor cells is required for upregulation of PD-L1 in tumor cells. Protein Cell 2016, 7, 538–543. [CrossRef] [PubMed]
40. Gao, Z.; Zhu, M.; Wu, Y.; Gao, P.; Qin, Z.; Wang, H. Interferon-lambda1 induces G1 phase cell cycle arrest and apoptosis in gastric carcinoma cells in vitro. Oncol. Rep. 2014, 32, 199–204. [PubMed]
41. Xia, W.; Hou, M. Macrophage migration inhibitory factor induces autophagy to resist hypoxia/serum deprivation-induced apoptosis via the AMP-activated protein kinase/mammalian target of rapamycin signaling pathway. Mol. Med. Rep. 2016, 13, 2619–2626. [CrossRef] [PubMed]
42. Chuang, Y.C.; Su, W.H.; Lei, H.Y.; Lin, Y.S.; Liu, H.S.; Chang, C.P.; Yeh, T.M. Macrophage migration inhibitory factor induces autophagy via reactive oxygen species generation. PLoS ONE 2012, 7, e37613. [CrossRef] [PubMed]
43. Soreide, K.; Sund, M. Epidemiological-molecular evidence of metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer. Cancer Lett. 2015, 356, 281–288. [CrossRef] [PubMed]
44. Kang, R.; Tang, D.; Livesey, K.M.; Schapiro, N.E.; Lotze, M.T.; Zeh, H.J., III. The Receptor for advanced glycation end-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxid. Redox Signal. 2011, 15, 2175–2184. [CrossRef] [PubMed]
45. Kang, R.; Tang, D.; Schapiro, N.E.; Livesey, K.M.; Farkas, A.; Loughran, P.; Bierhaus, A.; Lotze, M.T.; Zeh, H.J. The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ. 2010, 17, 666–676. [CrossRef] [PubMed]
46. Yang, X.; Yu, D.D.; Yan, F.; Jing, Y.Y.; Han, Z.P.; Sun, K.; Liang, L.; Hou, J.; Wei, L.X. The role of autophagy induced by tumor microenvironment in different cells and stages of cancer. Cell Biosci. 2015, 5, 14. [CrossRef] [PubMed]
47. Buchser, W.J.; Laskow, T.C.; Pavlik, P.J.; Lin, H.M.; Lotze, M.T. Cell-mediated autophagy promotes cancer cell survival. Cancer Res. 2012, 72, 2970–2979. [CrossRef] [PubMed]
48. Das, M.; Kaveri, S.V.; Bayry, J. Cross-presentation of antigens by dendritic cells: Role of autophagy. Oncotarget 2015, 6, 28527–28528. [PubMed]
49. Schmid, D.; Munz, C. Immune surveillance of intracellular pathogens via autophagy. Cell Death Differ. 2005, 12 (Suppl. 2), 1519–1527. [CrossRef] [PubMed]
50. Ireland, J.M.; Unanue, E.R. Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J. Exp. Med. 2011, 208, 2625–2632. [CrossRef] [PubMed]
51. Hernandez, C.; Huebener, P.; Schwabe, R.F. Damage-associated molecular patterns in cancer: A double-edged sword. Oncogene 2016, 35, 5931–5941. [CrossRef] [PubMed]
52. Land, W.G.; Agostinis, P.; Gasser, S.; Garg, A.D.; Linkermann, A. DAMP-induced allograft and tumor rejection: The circle is closing. Am. J. Transplant. 2016, 16, 3322–3337. [CrossRef] [PubMed]
53. Menzies, F.M.; Hourez, R.; Imarisio, S.; Raspe, M.; Sadiq, O.; Chandraratna, D.; O'kane, C.; Rock, K.L.; Reits, E.; Goldberg, A.L.; et al. Puromycin-sensitive aminopeptidase protects against aggregation-prone proteins via autophagy. Hum. Mol. Genet. 2010, 19, 4573–4586. [CrossRef] [PubMed]
54. Pietrocola, F.; Bravo-San Pedro, J.M.; Galluzzi, L.; Kroemer, G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy 2017. [CrossRef] [PubMed]
55. Lopez-Soto, A.; Bravo-San Pedro, J.M.; Kroemer, G.; Galluzzi, L.; Gonzalez, S. Involvement of autophagy in NK cell development and function. Autophagy 2017, 13, 633–636. [CrossRef] [PubMed]
56. Zarzynska, J.M. The importance of autophagy regulation in breast cancer development and treatment. BioMed Res. Int. 2014, 2014, 710345. [CrossRef] [PubMed]
57. Wei, H.; Guan, J.L. Blocking tumor growth by targeting autophagy and SQSTM1 in vivo. Autophagy 2015, 11, 854–855. [CrossRef] [PubMed]
58. Lee, J.G.; Shin, J.H.; Shim, H.S.; Lee, C.Y.; Kim, D.J.; Kim, Y.S.; Chung, K.Y. Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions. Respir. Res. 2015, 16, 138. [CrossRef] [PubMed]
59. Zou, Y.M.; Hu, G.Y.; Zhao, X.Q.; Lu, T.; Zhu, F.; Yu, S.Y.; Xiong, H. Hypoxia-induced autophagy contributes to radioresistance via c-Jun-mediated Beclin1 expression in lung cancer cells. J. Huazhong Univ. Sci. Technol. Med. Sci. 2014, 34, 761–767. [CrossRef] [PubMed]
60. Gdynia, G.; Keith, M.; Kopitz, J.; Bergmann, M.; Fassl, A.; Weber, A.N.; George, J.; Kees, T.; Zentgraf, H.W.; Wiestler, O.D.; et al. Danger signaling protein HMGB1 induces a distinct form of cell death accompanied by formation of giant mitochondria. Cancer Res. 2010, 70, 8558–8568. [CrossRef] [PubMed]
61. Pan, H.; Chen, L.; Xu, Y.; Han, W.; Lou, F.; Fei, W.; Liu, S.; Jing, Z.; Sui, X. Autophagy-associated immune responses and cancer immunotherapy. Oncotarget 2016, 7, 21235–21246. [PubMed]
62. Sell, S. Cancer immunotherapy: Breakthrough or “deja vu, all over again”? Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 2017, 39, 1010428317707764. [CrossRef] [PubMed]
63. Janji, B.; Viry, E.; Moussay, E.; Paggetti, J.; Arakelian, T.; Mgrditchian, T.; Messai, Y.; Noman, M.Z.; van Moer, K.; Hasmim, M.; et al. The multifaceted role of autophagy in tumor evasion from immune surveillance. Oncotarget 2016, 7, 17591–17607. [CrossRef] [PubMed]
64. Eskelinen, E.L.; Illert, A.L.; Tanaka, Y.; Schwarzmann, G.; Blanz, J.; von Figura, K.; Saftig, P. Role of LAMP-2 in lysosome biogenesis and autophagy. Mol. Biol. Cell 2002, 13, 3355–3368. [CrossRef] [PubMed]
65. Brest, P.; Corcelle, E.A.; Cesaro, A.; Chargui, A.; Belaid, A.; Klionsky, D.J.; Vouret-Craviari, V.; Hebuterne, X.; Hofman, P.; Mograbi, B. Autophagy and Crohn’s disease: At the crossroads of infection, inflammation, immunity, and cancer. Curr. Mol. Med. 2010, 10, 486–502. [CrossRef] [PubMed]
66. Takamura, A.; Komatsu, M.; Hara, T.; Sakamoto, A.; Kishi, C.; Waguri, S.; Eishi, Y.; Hino, O.; Tanaka, K.; Mizushima, N. Autophagy-deficient mice develop multiple liver tumors. Genes Dev. 2011, 25, 795–800. [CrossRef] [PubMed]
67. Morris, S.; Swanson, M.S.; Lieberman, A.; Reed, M.; Yue, Z.; Lindell, D.M.; Lukacs, N.W. Autophagy-mediated dendritic cell activation is essential for innate cytokine production and APC function with respiratory syncytial virus responses. J. Immunol. 2011, 187, 3953–3961. [CrossRef] [PubMed]
68. Qiu, Y.; Li, P.; Ji, C. Cell death conversion under hypoxic condition in tumor development and therapy. Int. J. Mol. Sci. 2015, 16, 25536–25551. [CrossRef] [PubMed]
69. Jaboin, J.J.; Hwang, M.; Lu, B. Autophagy in lung cancer. Methods Enzymol. 2009, 453, 287–304. [PubMed]
70. Tittarelli, A.; Janji, B.; van Moer, K.; Noman, M.Z.; Chouaib, S. The selective degradation of synaptic connexin 43 protein by hypoxia-induced autophagy impairs natural killer cell-mediated tumor cell killing. J. Biol. Chem. 2015, 290, 23670–23679. [CrossRef] [PubMed]
71. Vessoni, A.T.; Filippi-Chiela, E.C.; Menck, C.F.; Lenz, G. Autophagy and genomic integrity. Cell Death Differ. 2013, 20, 1444–1454. [CrossRef] [PubMed]
72. He, S.; Zhao, Z.; Yang, Y.; O’connell, D.; Zhang, X.; Oh, S.; Ma, B.; Lee, J.H.; Zhang, T.; Varghese, B.; et al. Truncating mutation in the autophagy gene UVRAG confers oncogenic properties and chemosensitivity in colorectal cancers. Nat. Commun. 2015, 6, 7839. [CrossRef] [PubMed]
73. Sharma, K.; Le, N.; Alotaibi, M.; Gewirtz, D.A. Cytotoxic autophagy in cancer therapy. Int. J. Mol. Sci. 2014, 15, 10034–10051. [CrossRef] [PubMed]
74. Shimizu, S.; Yoshida, T.; Tsujioka, M.; Arakawa, S. Autophagic cell death and cancer. Int. J. Mol. Sci. 2014, 15, 3145–3153. [CrossRef] [PubMed]
75. Koukourakis, M.I.; Mitrakas, A.G.; Giatromanolaki, A. Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: Evidence and issues to resolve. Br. J. Cancer 2016, 114, 485–496. [CrossRef] [PubMed]
76. Sui, X.; Chen, R.; Wang, Z.; Huang, Z.; Kong, N.; Zhang, M.; Han, W.; Lou, F.; Yang, J.; Zhang, Q.; et al. Autophagy and chemotherapy resistance: A promising therapeutic target for cancer treatment. Cell Death Dis. 2013, 4, e838. [CrossRef] [PubMed]
77. Huang, Q.; Wang, T.; Yang, L.; Wang, H.Y. Ginsenoside Rb2 alleviates hepatic lipid accumulation by restoring autophagy via induction of Sirt1 and activation of AMPK. Int. J. Mol. Sci. 2017, 18, 1063. [CrossRef] [PubMed]
78. Kim, K.Y.; Park, K.I.; Kim, S.H.; Yu, S.N.; Park, S.G.; Kim, Y.W.; Seo, Y.K.; Ma, J.Y.; Ahn, S.C. Inhibition of Autophagy promotes salinomycin-induced apoptosis via reactive oxygen species-mediated PI3K/AKT/mTOR and ERK/p38 MAPK-dependent signaling in human prostate cancer cells. Int. J. Mol. Sci. 2017, 18, 1088. [CrossRef] [PubMed]
79. Jarauta, V.; Jaime, P.; Gonzalo, O.; de Miguel, D.; Ramírez-Labrada, A.; Martínez-Lostao, L.; Anel, A.; Pardo, J.; Marzo, I.; Naval, J. Inhibition of autophagy with chloroquine potentiates carfilzomib-induced apoptosis in myeloma cells in vitro and in vivo. Cancer Lett. 2016, 382, 1–10. [CrossRef] [PubMed]
80. Hahm, E.R.; Sakao, K.; Singh, S.V. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate 2014, 74, 1209–1221. [CrossRef] [PubMed]
81. Torrens-Mas, M.; Pons, D.G.; Sastre-Serra, J.; Oliver, J.; Roca, P. SIRT3 silencing sensitizes breast cancer cells to cytotoxic treatments through an increment in ROS production. J. Cell. Biochem. 2017, 118, 397–406. [CrossRef] [PubMed]
82. Yang, C.; Shogren, K.L.; Goyal, R.; Bravo, D.; Yaszemski, M.J.; Maran, A. RNA-dependent protein kinase is essential for 2-methoxyestradiol-induced autophagy in osteosarcoma cells. PLoS ONE 2013, 8, e59406. [CrossRef] [PubMed]
83. Chen, D.; Rauh, M.; Buchfelder, M.; Eyupoglu, I.Y.; Savaskan, N. The oxido-metabolic driver ATF4 enhances temozolamide chemo-resistance in human gliomas. Oncotarget 2017. [CrossRef] [PubMed]
84. Pi, J.; Jin, H.; Jiang, J.; Yang, F.; Cai, H.; Yang, P.; Cai, J.; Chen, Z.W. Single molecule force spectroscopy for in-situ probing oridonin inhibited ROS-mediated EGF-EGFR interactions in living KYSE-150 cells. Pharmacol. Res. 2017, 119, 479–489. [CrossRef] [PubMed]
85. Ma, G.; Luo, W.; Lu, J.; Ma, D.L.; Leung, C.H.; Wang, Y.; Chen, X. Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells. Chem. Biol. Interact. 2016, 253, 1–9. [CrossRef] [PubMed]
86. Lin, Y.C.; Lin, J.F.; Wen, S.I.; Yang, S.C.; Tsai, T.F.; Chen, H.E.; Chou, K.Y.; Thomas, I.; Hwang, S. Chloroquine and hydroxychloroquine inhibit bladder cancer cell growth by targeting basal autophagy and enhancing apoptosis. Kaohsiung J. Med. Sci. 2017, 33, 215–223. [CrossRef] [PubMed]
87. Wang, Y.; Zhang, W.; Lv, Q.; Zhang, J.; Zhu, D. The critical role of quercetin in autophagy and apoptosis in HeLa cells. Tumour Biol. 2016, 37, 925–929. [CrossRef] [PubMed]
88. Zhou, X.; Yue, G.G.L.; Chan, A.M.L.; Tsui, S.K.W.; Fung, K.P.; Sun, H.; Pu, J.; Bik-San Lau, C. Eriocalyxin B, a novel autophagy inducer, exerts anti-tumor activity through the suppression of Akt/mTOR/p70S6K signaling pathway in breast cancer. Biochem. Pharmacol. 2017. [CrossRef] [PubMed]
89. Gong, K.; Zhang, Z.; Chen, Y.; Shu, H.B.; Li, W. Extracellular signal-regulated kinase, receptor interacting protein, and reactive oxygen species regulate shikonin-induced autophagy in human hepatocellular carcinoma. Eur J. Pharmacol. 2014, 738, 142–152. [CrossRef] [PubMed]